Abstract:Purpose. The aim of this study was to compare the metabolic load between adaptive support ventilation (ASV) and pressure support ventilation (PSV) modes in critically ill patients. Methods. Sequential 20 min ventilation by PSV followed by 20 min ASV in critically ill patients was assessed. ASV was set for full support, i.e., with the minute volume control set at the same level as the minute volume observed during PSV. The trial started from PSV 8 cmH2O and continued with high (PSV 12 cmH2O) to low (PSV 0) cond… Show more
“…6], nor can we predict which patients will fail at weaning [7,8]. the use of aSV for weaning and safe ventilation of patients has been proven in several trials, and our experience highlights the ease and safety of the use of this mode of ventilation [9][10][11].…”
Background:We describe the standardised management of patients in a chronic ventilation facility (CVF) and the rate of weaning of chronically ventilated patients off mechanical ventilation. This population of patients is transferred from acute care facilities where they have been deemed "non-weanable" and require prolonged ventilation.Methods: Admissions to our CVF were audited over a period of 3 years. We collected demographic and outcome data as well as the patients' length of stay and disposition. Weaning in our centre proceeds step-wise with a reduction in the adaptive support ventilation (ASV) minute ventilation target. Once the target reaches 50% of minute ventilation, spontaneous breathing trials are introduced and progressively lengthened until the patient is weaned.Results: In total, 125 patients were admitted during the 3 years. 109 were not weaned, and 16 were weaned, i.e. 12.8% of patients were safely weaned off mechanical ventilation. Of the patients not weaned, the mortality rate was 34.8%, and 38.5% were discharged alive to either home or another facility.
Conclusions:Weaning chronically ventilated patients is possible without intensivists or respiratory therapists on staff when a standardised approach/manner is implemented. However, weaning success appears to be mainly related to patients' co-morbidities.
“…6], nor can we predict which patients will fail at weaning [7,8]. the use of aSV for weaning and safe ventilation of patients has been proven in several trials, and our experience highlights the ease and safety of the use of this mode of ventilation [9][10][11].…”
Background:We describe the standardised management of patients in a chronic ventilation facility (CVF) and the rate of weaning of chronically ventilated patients off mechanical ventilation. This population of patients is transferred from acute care facilities where they have been deemed "non-weanable" and require prolonged ventilation.Methods: Admissions to our CVF were audited over a period of 3 years. We collected demographic and outcome data as well as the patients' length of stay and disposition. Weaning in our centre proceeds step-wise with a reduction in the adaptive support ventilation (ASV) minute ventilation target. Once the target reaches 50% of minute ventilation, spontaneous breathing trials are introduced and progressively lengthened until the patient is weaned.Results: In total, 125 patients were admitted during the 3 years. 109 were not weaned, and 16 were weaned, i.e. 12.8% of patients were safely weaned off mechanical ventilation. Of the patients not weaned, the mortality rate was 34.8%, and 38.5% were discharged alive to either home or another facility.
Conclusions:Weaning chronically ventilated patients is possible without intensivists or respiratory therapists on staff when a standardised approach/manner is implemented. However, weaning success appears to be mainly related to patients' co-morbidities.
“…The ventilation mode may unjustly influence measured EE by directly affecting the measured gas flow used for calculation [ 15 , 82 , 83 ]. As the device uses the amount of inspired and expired N 2 as a control to define the amount of inspired and expired oxygen and carbon dioxide, the amount of N 2 will be too low to get a reliable result, when the fraction of inspired oxygen is too high.…”
The use of indirect calorimetry is strongly recommended to guide nutrition therapy in critically ill patients, preventing the detrimental effects of under- and overfeeding. However, the course of energy expenditure is complex, and clinical studies on indirect calorimetry during critical illness and convalescence are scarce. Energy expenditure is influenced by many individual and iatrogenic factors and different metabolic phases of critical illness and convalescence. In the first days, energy production from endogenous sources appears to be increased due to a catabolic state and is likely near-sufficient to meet energy requirements. Full nutrition support in this phase may lead to overfeeding as exogenous nutrition cannot abolish this endogenous energy production, and mitochondria are unable to process the excess substrate. However, energy expenditure is reported to increase hereafter and is still shown to be elevated 3 weeks after ICU admission, when endogenous energy production is reduced, and exogenous nutrition support is indispensable. Indirect calorimetry is the gold standard for bedside calculation of energy expenditure. However, the superiority of IC-guided nutritional therapy has not yet been unequivocally proven in clinical trials and many practical aspects and pitfalls should be taken into account when measuring energy expenditure in critically ill patients. Furthermore, the contribution of endogenously produced energy cannot be measured. Nevertheless, routine use of indirect calorimetry to aid personalized nutrition has strong potential to improve nutritional status and consequently, the long-term outcome of critically ill patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.